REGISTERED NUMBER: |
LONDON LUNG LABORATORY LIMITED |
Unaudited Financial Statements |
for the Year Ended 31 December 2024 |
REGISTERED NUMBER: |
LONDON LUNG LABORATORY LIMITED |
Unaudited Financial Statements |
for the Year Ended 31 December 2024 |
LONDON LUNG LABORATORY LIMITED (REGISTERED NUMBER: 04336530) |
Contents of the Financial Statements |
for the year ended 31 December 2024 |
Page |
Company Information | 1 |
Balance Sheet | 2 |
Notes to the Financial Statements | 3 |
LONDON LUNG LABORATORY LIMITED |
Company Information |
for the year ended 31 December 2024 |
Directors: |
Secretary: |
Registered office: |
Registered number: |
Accountants: |
New Derwent House |
69-73 Theobalds Road |
London |
WC1X 8TA |
Bankers: |
440 Strand |
London |
WC2R 0QS |
LONDON LUNG LABORATORY LIMITED (REGISTERED NUMBER: 04336530) |
Balance Sheet |
31 December 2024 |
2024 | 2023 |
Notes | £ | £ |
Fixed assets |
Tangible assets | 4 |
Current assets |
Debtors | 5 |
Cash at bank |
Creditors |
Amounts falling due within one year | 6 | ( |
) | ( |
) |
Net current liabilities | ( |
) | ( |
) |
Total assets less current liabilities | ( |
) | ( |
) |
Capital and reserves |
Called up share capital | 7 |
Retained earnings | 8 | ( |
) | ( |
) |
Shareholders' funds | ( |
) | ( |
) |
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
The financial statements were approved by the Board of Directors and authorised for issue on |
LONDON LUNG LABORATORY LIMITED (REGISTERED NUMBER: 04336530) |
Notes to the Financial Statements |
for the year ended 31 December 2024 |
1. | Statutory information |
London Lung Laboratory Limited is a private company, limited by shares, registered in England and Wales. The company's registered number is 04336530 and the registered office address being 54 New Cavendish Street, London, W1G 8TQ. |
2. | Accounting policies |
Basis of preparing the financial statements |
Key sources of estimation uncertainty and judgements |
Preparation of the financial statements requires management to make significant judgements and estimates in determining the carrying amounts of certain assets and liabilities. Management makes assumptions of the effects of uncertain future events on those assets and liabilities at the balance sheet date. The management's estimates and assumptions are based on historical experience and expectation of future events and are reviewed periodically. This disclosure excludes uncertainty over future events and judgement in respect of measuring financial instruments. There are no further significant judgements or estimates. |
Turnover |
Turnover comprises revenue recognised by the company in respect of goods and services supplied during the year, exclusive of Value Added Tax. |
Tangible fixed assets |
Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of fixed assets, less their estimated residual value, over their expected useful lives on the following bases: |
Office equipment - 15% reducing balance |
Going concern |
The company meets its day to day working capital requirements through the support of the directors and shareholders of the company. On this basis, the directors consider it appropriate to prepare the financial statements on the going concern basis. |
Financial instruments |
Financial assets and financial liabilities are recognised in the balance sheet when the company becomes a party to the contractual provisions of the instrument. |
Trade and other debtors and creditors are classified as basic financial instruments and measured at initial recognition at transaction price. Debtors and creditors are subsequently measured at amortised cost using the effective interest rate method. A provision is established when there is objective evidence that the company will not be able to collect all amounts due. |
Cash and cash equivalents are classified as basic financial instruments and comprise cash in hand and at bank, which are an integral part of the company's cash management. |
3. | Employees and directors |
The average number of employees during the year was |
LONDON LUNG LABORATORY LIMITED (REGISTERED NUMBER: 04336530) |
Notes to the Financial Statements - continued |
for the year ended 31 December 2024 |
4. | Tangible fixed assets |
Office |
equipment |
£ |
Cost |
At 1 January 2024 |
Additions |
At 31 December 2024 |
Depreciation |
At 1 January 2024 |
Charge for year |
At 31 December 2024 |
Net book value |
At 31 December 2024 |
At 31 December 2023 |
5. | Debtors: amounts falling due within one year |
2024 | 2023 |
£ | £ |
Trade debtors |
6. | Creditors: amounts falling due within one year |
2024 | 2023 |
£ | £ |
Taxation and social security |
Other creditors |
7. | Called up share capital |
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 2024 | 2023 |
value: | £ | £ |
Ordinary | £1 | 100 | 100 |
8. | Reserves |
Retained |
earnings |
£ |
At 1 January 2024 | ( |
) |
Deficit for the year | ( |
) |
At 31 December 2024 | ( |
) |
9. | Related party disclosures |
The company was under the control of the directors throughout the current and prior year. |
At the balance sheet date, a director was owed £18,435 (2023: £18,435). |